AJOVista LLC Purchases Shares of 178 Humana Inc. (NYSE:HUM)

AJOVista LLC purchased a new position in Humana Inc. (NYSE:HUM) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 178 shares of the insurance provider’s stock, valued at approximately $81,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Rakuten Securities Inc. acquired a new stake in Humana during the fourth quarter valued at approximately $25,000. Gradient Investments LLC boosted its stake in shares of Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares in the last quarter. Cetera Trust Company N.A acquired a new position in shares of Humana in the 4th quarter worth $28,000. Nvwm LLC raised its position in shares of Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after purchasing an additional 25 shares during the period. Finally, Turtle Creek Wealth Advisors LLC purchased a new stake in shares of Humana during the fourth quarter valued at $55,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent analyst reports. Mizuho cut their price objective on Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, January 26th. UBS Group dropped their price target on Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. TheStreet lowered Humana from a “b” rating to a “c+” rating in a research report on Monday, January 8th. Argus downgraded Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Humana from a “buy” rating to a “hold” rating and decreased their price target for the stock from $595.00 to $360.00 in a report on Thursday, January 25th. Eleven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $424.50.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of Humana stock in a transaction dated Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the transaction, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.32% of the stock is currently owned by corporate insiders.

Humana Stock Down 0.1 %

Shares of NYSE HUM traded down $0.44 during mid-day trading on Friday, reaching $320.54. 1,802,675 shares of the company traded hands, compared to its average volume of 1,607,966. The company’s fifty day moving average is $324.12 and its two-hundred day moving average is $388.34. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $541.21. The stock has a market cap of $38.63 billion, a PE ratio of 19.96, a price-to-earnings-growth ratio of 1.86 and a beta of 0.49.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The company had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter last year, the company posted $9.38 earnings per share. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. On average, analysts expect that Humana Inc. will post 16.18 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.10%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.